Sunshine Biopharma Inc. (SBFM) › Capital ExpendituresSunshine Biopharma Inc. (SBFM) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $02015: $4.8K2016: $3.4K2017: $3.7K2018: $18.9K2019: $8602020: $1.2K2021: $02022: $194.0K2023: $82.3K2024: $1.66M2025: $174.5K$174.5K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$174.5K-89.5%2024$1.66M+1914.6%2023$82.3K-57.6%2022$194.0K—2021$0-100.0%2020$1.2K+38.5%2019$860-95.4%2018$18.9K+407.0%2017$3.7K+8.1%2016$3.4K-28.2%2015$4.8K—2014$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share